COMMUNIQUÉS West-GlobeNewswire

LUKE Calls for National Partnerships to Help America’s Heroes Flourish
24/09/2025
NASHVILLE, Tenn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- As the American Association of Christian Counselors (AACC) World Conference in Nashville opens, LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing [...]
Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza
24/09/2025
- Update based on FDA End-of- Phase 2 meeting outcome - Phase 3 study start accelerated by six months, in time for the fall 2025 Northern Hemisphere flu season - A single Phase 3 trial of CD388, if successful, may be [...]
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
24/09/2025
FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor signaling inhibitor (ASRI) and pre-chemotherapy setting FG-3180 to [...]
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
24/09/2025
~ Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by cUHDRS compared to a propensity score-matched external control ~ ~ High-dose [...]
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
24/09/2025
IMDX to host symposium on Wednesday, September 24 th to discuss GraftAssureIQ™ at International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) annual meeting Presenting on GraftAssureIQ at [...]
Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit
24/09/2025
TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Healthcare must be recognized as the world’s most strategic investment in security, prosperity, and resilience—not as a financial burden—declared H.E. Dr. Majid Alfayyadh, [...]
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
24/09/2025
~ Term of current $50 million debt outstanding extended from January 2027 to October 2030 ~ ~ Additional $100 million available subject to regulatory and financial milestones ~ ~ Additional $25 million available subject [...]
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
24/09/2025
Program to Provide Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 3 rd , 2025 SOUTH SAN FRANCISCO, Calif., Sept. 24, [...]
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
24/09/2025
TOKYO and CAMBRIDGE, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: [...]
Kura Oncology to Participate in Upcoming Investor Conference
24/09/2025
SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
24/09/2025
NAARDEN, The Netherlands and MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health
24/09/2025
New Alignment Health study shows nearly 2 in 5 seniors who experience loneliness say it’s impacting their health, 1 in 4 who have medical debt owe debt equal to 4+ months of living expenses ORANGE, Calif., Sept. 24, [...]
Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
24/09/2025
Engagement Will Expand Daré’s Engagement in Advancing Women’s Health Innovation and Provide Insights into One of the Most Significant Unmet Needs in Maternal Care SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Daré [...]
BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025
24/09/2025
Company honored in its commitment to patients and families living with mitochondrial disease; invites the community to walk with BPGbio colleagues and MitoAction BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- BPGbio , Inc [...]
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
24/09/2025
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell lung cancer (NSCLC) CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- MAIA [...]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
24/09/2025
Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamine Granting of Suitability Petition enables re-filing of Abbreviated New Drug Application ( [...]
EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation
24/09/2025
Innovator of HD-EEG releases world’s most advanced EEG brain monitoring technology for neuroscience research MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- EGI has unveiled the Geodesic EEG System 500, the world’s [...]
Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position
24/09/2025
Expanded microbiology lab and analytical chemistry capabilities position Ritedose for accelerated growth. $17+ million investment fuels innovation and scale in drug development. COLUMBIA, S.C., Sept. 24, 2025 (GLOBE [...]
Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)
24/09/2025
Intends to Initiate Phase 1b Clinical Trial in TNBC at Mayo Clinic in Fourth Quarter 2025 FLORHAM PARK, N.J. and LONDON and CHARLOTTESVILLE, Va., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (“ [...]

Pages